Pegavision Corporation (TPE:6491)
Taiwan · Delayed Price · Currency is TWD 312.50
-5.50 (-1.73%)
Aug 11, 2025, 2:36 PM CST
Paramount Global Market Cap
Pegavision has a market cap or net worth of 24.34 billion as of August 8, 2025. Its market cap has decreased by -29.17% in one year.
Market Cap
24.34B
Enterprise Value
20.90B
Revenue
6.67B
Ranking
n/a
PE Ratio
14.93
Stock Price
$312.50
Market Cap Chart
Since December 30, 2014, Pegavision's market cap has increased from 9.60B to 24.34B, an increase of 153.50%. That is a compound annual growth rate of 9.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 24.80B | -15.65% |
| Dec 31, 2024 | 29.41B | -4.92% |
| Dec 29, 2023 | 30.93B | 4.20% |
| Dec 30, 2022 | 29.68B | -0.70% |
| Dec 30, 2021 | 29.89B | 50.88% |
| Dec 31, 2020 | 19.81B | 55.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 203.96B |
| PharmaEssentia | 169.97B |
| Bora Pharmaceuticals Co., LTD. | 88.98B |
| Lotus Pharmaceutical | 57.98B |
| Oneness Biotech | 31.13B |
| Polaris Group | 27.81B |
| Center Laboratories | 27.03B |
| Lumosa Therapeutics | 23.97B |